Targeting microRNA-122 to treat hepatitis C virus infection

Viruses

Volumn 2, Issue 7, 2010, Pages 1382-1393

  Jopling, Catherine L ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Hepatitis C virus; MicroRNA 122

Indexed keywords

2' FLUORO RNA; 2' O METHOXYETHYL RNA; 2' OME RNA; ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; BOCEPREVIR; LIPOSOME; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 122; MICRORNA 122 INHIBITOR; MICRORNA INHIBITOR; MIRAVIRSEN; OLIGOMER; PEGINTERFERON ALPHA; PEPTIDE NUCLEIC ACID; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DERIVATIVE; RNA OLIGOMER; TELAPREVIR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VIRUS RNA;

5' UNTRANSLATED REGION; CHIMPANZEE; DRUG MEGADOSE; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIFE CYCLE; LIVER FUNCTION; LOW DRUG DOSE; MAMMAL; MOLECULAR INTERACTION; NONHUMAN; REVIEW; RNA BINDING; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ANIMALIA; HEPATITIS C VIRUS; MAMMALIA; PAN;

EID: 79952164510     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2071382     Document Type: Review

References (38)

1. Filipowicz, W.; Bhattacharyya, S.N.; Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 2008, 9, 102-114.
2. Kim, V.N.; Nam J.W. Genomics of microRNA. Trends Genet. 2006, 22, 165-173.
3. Griffiths-Jones, S.; Saini, H.K.; van Dongen, S.; Enright, A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36, D154-158.
4. Lagos-Quintana, M.; Rauhut, R.; Yalcin, A.; Meyer, J.; Lendeckel, W.; Tuschl, T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12, 735-739.
5. Croce, C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10, 704-714
6. Carthew, R.W.; Sontheimer, E.J. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009, 136, 642-655.
7. Bartel, D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136, 215-233.
8. Fabian, M.R.; Mathonnet, G.; Sundermeier, T.; Mathys, H.; Zipprich, J.T.; Svitkin, Y.V.; Rivas, F.; Jinek, M.; Wohlschlegel, J.; Doudna, J.A.; et al. Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol. Cell 2009, 35, 868-880.
9. Umbach, J.L.; Cullen, B.R. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 2009, 23, 1151-1164.
10. Skalsky, R.L.; Cullen, B.R. Viruses, microRNAs, and Host Interactions. Annu. Rev. Microbiol. 2010, in press, doi:10.1146/annurev.micro.112408.134243.
11. Kloosterman, W.P.; Wienholds, E.; de Bruijn, E.; Kauppinen, S.; Plasterk, R.H. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat. Methods 2006, 3, 27-29.
12. Thomson, B.J. Hepatitis C virus: the growing challenge. Br. Med. Bull. 2009, 89, 153-167.
13. Lindenbach, B.D.; Rice, C.M. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436, 933-938.
14. Pestova, T.V.; Shatsky, I.N.; Fletcher, S.P.; Jackson, R.J.; Hellen, C.U. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 1998, 12, 67-83.
15. Jopling, C.L.; Yi, M.; Lancaster, A.M.; Lemon, S.M.; Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309, 1577-1581.
16. Jopling, C.L.; Schütz, S.; Sarnow, P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008, 4, 77-85.
17. Jangra, R.K.; Yi, M.; Lemon, S.M. miR-122 Regulation of Hepatitis C Virus Translation and Infectious Virus Production. J. Virol. 2010, 84, 6615-6625.
18. Randall, G.; Panis, M.; Cooper, J.D.; Tellinghuisen, T.L.; Sukhodolets, K.E.; Pfeffer, S.; Landthaler, M.; Landgraf, P.; Kan, S.; Lindenbach, B.D.; et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 12884-12889.
19. Henke, J.I.; Goergen, D.; Zheng, J.; Song, Y.; Schuttler, C.G.; Fehr, C.; Junemann, C.; Niepmann, M. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 2008, 27, 3300-3310.
20. Norman, K.L.; Sarnow, P. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J. Virol. 2010, 84, 666-670.
21. Hutvágner, G.; Simard, M.J.; Mello, C.C.; Zamore, P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2004, 2, E98.
22. Davis, S.; Lollo, B.; Freier, S.; Esau, C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006, 34, 2294-2304.
23. Davis, S.; Propp, S.; Freier, S.M.; Jones, L.E.; Serra, M.J.; Kinberger, G.; Bhat, B.; Swayze, E.E.; Bennett, C.F.; Esau, C. Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Res. 2009, 37, 70-77.
24. Elmen, J.; Lindow, M.; Silahtaroglu, A.; Bak, M.; Christensen, M.; Lind-Thomsen, A.; Hedtjarn, M.; Hansen, J.B.; Hansen, H.F.; Straarup, E.M.; et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 2008, 36, 1153-1162.
25. Elmen, J.; Lindow, M.; Schütz, S.; Lawrence, M.; Petri, A.; Obad, S.; Lindholm, M.; Hedtjarn, M.; Hansen, H.F.; Berger, U.; et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452, 896-899.
26. Lanford, R.E.; Hildebrandt-Eriksen, E.S.; Petri, A.; Persson, R.; Lindow, M.; Munk, M.E.; Kauppinen, S.; Ørum, H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327, 198-201.
27. Seto, A.G. The road toward microRNA therapeutics. Int. J. Biochem. Cell Biol. 2010, in press, doi:10.1016/j.biocel.2010.03.003.
28. Krützfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438, 685-689.
29. Fabani, M.M.; Gait, M.J. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA 2008, 14, 336-346.
30. Fabani, M.M.; Abreu-Goodger, C.; Williams, D.; Lyons, P.A.; Torres, A.G.; Smith, K.G.; Enright, A.J.; Gait, M.J.; Vigorito, E. Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res. 2010, in press, doi:10.1093/nar/gkq160.
31. Esau, C.C. Inhibition of microRNA with antisense oligonucleotides. Methods 2008, 44, 55-60.
32. Ebert, M.S.; Neilson, J.R.; Sharp, P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4, 721-726.
33. Esau, C.; Davis, S.; Murray, S.F.; Yu, X.X.; Pandey, S.K.; Pear, M.; Watts, L.; Booten, S.L.; Graham, M.; McKay, R.; et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3, 87-98.
34. Preiss, D.; Sattar, N. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin. Endocrinol. (Oxf.) 2009, 70, 815-828.
35. Boonstra, A.; van der Laan, L.J.; Vanwolleghem, T.; Janssen, H.L. Experimental models for hepatitis C viral infection. Hepatology 2009, 50, 1646-1655.
36. Sarasin-Filipowicz, M.; Krol, J.; Markiewicz, I.; Heim, M.H.; Filipowicz, W. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 2009, 15, 31-33.
37. Chang, J.; Nicolas, E.; Marks, D.; Sander, C.; Lerro, A.; Buendia, M.A.; Xu, C.; Mason, W.S.; Moloshok, T.; Bort, R.; Zaret, K.S.; Taylor, J.M. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biology 2004, 1, 106-113.
38. Nelson, D.R. Hepatitis C drug development at a crossroads. Hepatology 2009, 50, 997-999.